MANES, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 4.942
AS - Asia 4.325
EU - Europa 3.363
AF - Africa 291
SA - Sud America 267
Continente sconosciuto - Info sul continente non disponibili 245
OC - Oceania 8
Totale 13.441
Nazione #
US - Stati Uniti d'America 4.853
VN - Vietnam 1.244
SG - Singapore 1.100
CN - Cina 1.064
GB - Regno Unito 788
IT - Italia 753
DE - Germania 396
HK - Hong Kong 320
SE - Svezia 271
UA - Ucraina 253
FR - Francia 226
BR - Brasile 179
IN - India 171
RU - Federazione Russa 158
IE - Irlanda 156
NL - Olanda 109
CI - Costa d'Avorio 84
ZA - Sudafrica 78
JP - Giappone 70
TG - Togo 62
KR - Corea 59
CA - Canada 56
BD - Bangladesh 55
EE - Estonia 52
JO - Giordania 46
FI - Finlandia 45
PH - Filippine 35
AR - Argentina 34
CH - Svizzera 28
TH - Thailandia 27
BG - Bulgaria 24
SC - Seychelles 24
ID - Indonesia 22
BE - Belgio 18
CO - Colombia 17
PL - Polonia 17
IQ - Iraq 15
NG - Nigeria 15
TW - Taiwan 15
AT - Austria 14
EC - Ecuador 14
IR - Iran 14
TR - Turchia 14
MX - Messico 10
PK - Pakistan 10
SA - Arabia Saudita 9
GR - Grecia 8
JM - Giamaica 8
VE - Venezuela 8
ES - Italia 7
AU - Australia 6
MY - Malesia 6
EG - Egitto 5
PS - Palestinian Territory 5
UZ - Uzbekistan 5
AL - Albania 4
CL - Cile 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
HN - Honduras 4
HR - Croazia 4
KE - Kenya 4
LT - Lituania 4
OM - Oman 4
PE - Perù 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
ET - Etiopia 3
MA - Marocco 3
MK - Macedonia 3
RO - Romania 3
UY - Uruguay 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EU - Europa 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
Totale 13.192
Città #
Singapore 745
Southend 676
Chandler 452
Ashburn 446
Fairfield 418
Hong Kong 303
San Jose 276
Santa Clara 255
Ho Chi Minh City 242
Hanoi 237
Woodbridge 204
Wilmington 195
Dong Ket 188
Houston 182
Beijing 175
Seattle 166
Princeton 162
Dublin 155
Cambridge 145
Ann Arbor 140
Jacksonville 139
Hefei 123
Council Bluffs 118
Boardman 99
Bologna 91
Abidjan 84
Lauterbourg 77
Padova 77
Nanjing 74
Milan 73
Westminster 68
Tokyo 65
Lomé 62
Los Angeles 61
Berlin 53
Turin 52
Buffalo 50
New York 50
Amman 46
Jinan 45
São Paulo 45
Seoul 42
Haiphong 35
Helsinki 35
Saint Petersburg 35
Shenyang 35
Medford 32
Da Nang 29
Dallas 29
Hebei 28
Mülheim 28
San Diego 23
Changsha 22
Guangzhou 22
Nanchang 21
Sofia 21
Hangzhou 20
Jiaxing 20
Bern 19
Des Moines 19
Rome 19
Bengaluru 18
Brussels 18
Redondo Beach 18
Mahé 17
Munich 17
Dearborn 16
London 16
Abeokuta 15
Frankfurt am Main 15
The Dalles 15
Tianjin 15
Toronto 15
Florence 14
Montreal 14
Warsaw 13
Amsterdam 12
Can Tho 12
Orem 12
Shanghai 12
Zhengzhou 12
Johannesburg 11
Monmouth Junction 11
Olalla 11
Paris 11
Phoenix 11
Biên Hòa 10
Bremen 10
Falkenstein 10
Ningbo 10
Ninh Bình 10
Redmond 10
Verona 10
Bogotá 9
Chengdu 9
Falls Church 9
Norwalk 9
Springfield 9
Yubileyny 9
Ardabil 8
Totale 8.331
Nome #
Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells 275
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 268
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 259
Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients 256
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension 255
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: Real-world insights 247
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 239
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 236
Pulmonary Arterial Hypertension associated to connective tissue diseases 230
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 227
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes 219
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 215
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 207
Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease 205
BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis 199
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration 197
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 196
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 193
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 193
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 188
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines 186
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 182
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. 180
Genere femminile e ipertensione arteriosa polmonare: una relazione complessa Female gender and pulmonary arterial hypertension: a complex relationship 180
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. 178
The endothelin system in pulmonary arterial hypertension. 176
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare. 176
New insights on pulmonary arterial hypertension. 175
Current therapeutic approaches to pulmonary arterial hypertension. 175
Evaluation of pulmonary arterial hypertension. 173
BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. 173
Sildenafil therapy in patients with porto-pulmonary hypertension 171
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. 170
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors 169
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 168
Cardiologia pediatrica. Problematiche cliniche 167
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. 164
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. 161
Pulmonary arterial hypertension. Part II: Medical and surgical treatment 161
Effetti del sildenafil in soggetti con cuore polmonare cronico tromboembolico 159
Pulmonary veno-occlusive disease: the role of CT 157
Reverse remodelling of ECG changes in idiopathic pulmonary arterial hypertension patients responders to chronic treatment with calcium channel blockers 152
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare. 151
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome. 150
Effetti a lungo termine del trattamento con sildenafil nei pazienti affetti da ipertensione arteriosa polmonare associata a cardiopatie congenite con shunt 147
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 147
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease 147
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools 147
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension 146
Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects 145
Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. 144
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 144
L-arginine supplementation in pulmonary arterial hypertension 140
Exercise training in pulmonary hypertension: improving performance but waiting for outcome 140
Epidemiology of patients referred to a specialised pulmonary hypertension center 139
The difficult diagnosis of pulmonary vascular disease in heart failure 139
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension 138
L. Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S. Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes, N. Galiè, A. Branzi 138
Conventional Medical Therapies in the treatment of pulmonary hypertension 136
Progressi nel trattamento delle malattie della circolazione polmonare 136
Comparative analysis of clinical trials and evidence-based treatment algorithm for pulmonary arterial hypertension 135
Pulmonary arterial hypertension in the pediatric age. 131
Current medical therapies in pulmonary arterial hypertension 130
New Treatment Strategies for Pulmonary Arterial Hypertension 129
Experience with inheritable pulmonary arterial hypertension in a specialised center 129
Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research† 128
Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting 128
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. 126
Long-term outcomes after pulmonary endarterectomy 123
GPs meet rare lung disorders task force factsheet: Pulmonary arterial hypertension 120
Pulmonary hypertension 118
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. 116
Chronic Thromboembolic Pulmonary Hypertension and Chronic ThromboembolicPulmonary Disease (CTEPD): Clinical and Interventional Perspective 109
Pulmonary Hypertension: Lessons from Adults 107
Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed. 105
Pulmonary Hypertension 101
Predictive value of tricuspid regurgitation area in idiopathic pulmonary arterial hypertension patients treated according to current guidelines 100
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease 97
Malattie del circolo polmonare 91
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension 89
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience 87
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension 77
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds 69
Influence of age in the assessment of therapeutic response in patients with pulmonary arterial hypertension 65
Totale 13.441
Categoria #
all - tutte 36.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.229 0 0 90 132 110 77 30 70 52 113 282 273
2022/20231.820 185 251 80 249 87 145 50 90 346 86 143 108
2023/2024317 25 64 22 30 28 40 24 9 12 24 26 13
2024/20251.884 60 338 225 100 336 86 109 61 32 122 42 373
2025/20264.052 321 373 342 286 481 221 346 117 927 334 163 141
2026/2027271 99 150 22 0 0 0 0 0 0 0 0 0
Totale 13.441